HistoRx

Branford, United States Founded: 2001 • Age: 25 yrs Acquired By Genoptix
Tissue-based diagnostic solutions for research and clinical pathology markets
Request Access

About HistoRx

HistoRx is a company based in Branford (United States) founded in 2001 was acquired by Genoptix in September 2012.. HistoRx has raised $13.26 million across 5 funding rounds from investors including HHS, Maven Capital Partners and Genoptix. HistoRx operates in a competitive market with competitors including Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.

  • Headquarter Branford, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $13.26 M (USD)

    in 5 rounds

  • Latest Funding Round
    $2.6 M (USD), Series B

    May 25, 2011

  • Investors
    HHS

    & 6 more

  • Employee Count
    Employee Count
  • Acquired by
    Genoptix

    (Sep 09, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of HistoRx

HistoRx has successfully raised a total of $13.26M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $2.6 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series B — $2.6M
  • First Round

    (14 Sep 2004)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2011 Amount Series B - HistoRx Valuation

investors

Dec, 2009 Amount Series B - HistoRx Valuation

investors

Oct, 2008 Amount Grant - HistoRx Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in HistoRx

HistoRx has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Maven Capital Partners and Genoptix. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Multiple sectors are targeted for private equity investments.
Founded Year Domain Location
-
Founded Year Domain Location
Corporate-backed venture capital firm focused on the healthcare sector
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by HistoRx

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - HistoRx

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Historx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of HistoRx

HistoRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of in-vitro diagnostic products for the detection of cancer
domain founded_year HQ Location
Real-time cell analyzers are developed for oxygen consumption monitoring.
domain founded_year HQ Location
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
domain founded_year HQ Location
Cell-based assays for drug discovery are developed via CMOS platform.
domain founded_year HQ Location
3D cell culture products are developed for drug discovery applications.
domain founded_year HQ Location
Metastatic cancer properties are targeted by Remedy Plan's containment therapy.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Historx

Frequently Asked Questions about HistoRx

When was HistoRx founded?

HistoRx was founded in 2001 and raised its 1st funding round 3 years after it was founded.

Where is HistoRx located?

HistoRx is headquartered in Branford, United States. It is registered at Branford, Connecticut, United States.

Is HistoRx a funded company?

HistoRx is a funded company, having raised a total of $13.26M across 5 funding rounds to date.

What does HistoRx do?

HistoRx was founded in 2001 in Branford, United States, focusing on tissue-based diagnostics in the pathology sector. Proprietary AQUA technology is utilized to analyze protein locations and quantities in cell sub-compartments while preserving spatial relationships in tissue samples and microarrays. Operations target research and clinical applications. The company was acquired by Genoptix, a Novartis subsidiary, in 2012.

Who are the top competitors of HistoRx?

HistoRx's top competitors include CytoTronics, Kiyatec and Remedy Plan.

Who are HistoRx's investors?

HistoRx has 7 investors. Key investors include HHS, Maven Capital Partners, Genoptix, Brook Venture Partners, and Navigator Technology Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available